Showing results (41-50 of 969) with videos related to
Sort By:
Pageof 97
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Managing Philadelphia chromosome-positive acute lymphoblastic leukemia: role of tyrosine kinase inhibitorsFarhad RavandiHematology. American Society of Hematology. Education Program|December 10, 2017
Current management of Philadelphia chromosome positive ALL and the role of stem cell transplantationFarhad RavandiBlood Cancer Journal|September 19, 2024
Current status and research directions in acute myeloid leukemiaHagop Kantarjian, Gautam Borthakur, Naval Daver, et al.Therapeutic Advances in Hematology|April 2, 2014
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failureHady Ghanem, Guillermo Garcia-Manero, Stefan Faderl, et al.American Journal of Clinical Pathology|June 15, 2016
Comparison of Multiparameter Flow Cytometry Immunophenotypic Analysis and Quantitative RT-PCR for the Detection of Minimal Residual Disease of Core Binding Factor Acute Myeloid LeukemiaJuan Ouyang, Maitrayee Goswami, Jie Peng, et al.American Journal of Hematology|January 28, 2025
Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid LeukemiaQing Wei, Shimin Hu, Sanam Loghavi, et al.American Journal of Hematology|May 15, 2021
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemiaNitin Jain, Abhishek Maiti, Farhad Ravandi, et al.Haematologica|August 10, 2012
Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignanciesGautam Borthakur, Michael G Rosenblum, Moshe Talpaz, et al.Pageof 97